WASHINGTON -- Doctors may soon have two new drug options to treat patients with hepatitis C, just as the liver-destroying virus becomes a major public health issue for millions of Americans reaching retirement age. The Food and Drug Administration holds a public meeting this week to review two experimental medications from two U.S.